PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Monte Rosa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Monte Rosa Therapeutics, Inc. GLUE | PRICE T ROWE ASSOCIATES INC | 6,601,141 10.800% | 1,504,354 (+29.52%) | Filing |
| 2024-04-10 12:58 pm Purchase | 2024-03-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | PRICE T ROWE ASSOCIATES INC | 5,096,787 10.200% | 155,080 (+3.14%) | Filing |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | PRICE T ROWE ASSOCIATES INC | 4,941,707 9.900% | 1,258,277 (+34.16%) | Filing |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | PRICE T ROWE ASSOCIATES INC | 3,683,430 7.600% | -1,175,197 (-24.19%) | Filing |
| 2022-02-10 1:16 pm Purchase | 2022-01-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | PRICE T ROWE ASSOCIATES INC | 4,858,627 10.400% | 711,708 (+17.16%) | Filing |
| 2022-02-10 1:13 pm Purchase | 2021-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | PRICE T ROWE ASSOCIATES INC | 4,146,919 8.900% | 4,146,919 (New Position) | Filing |